Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.
2.

Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.

Humphrey EL, Williams JH, Davie MW, Marshall MJ.

Bone. 2006 May;38(5):652-61.

PMID:
16298558
3.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68.

5.

Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.

Viereck V, Gründker C, Blaschke S, Siggelkow H, Emons G, Hofbauer LC.

J Cell Biochem. 2002;84(4):725-35.

PMID:
11835398
8.

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gründker C, Hofbauer LC.

Biochem Biophys Res Commun. 2002 Mar 1;291(3):680-6.

PMID:
11855844
9.

Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.

Viereck V, Gründker C, Friess SC, Frosch KH, Raddatz D, Schoppet M, Nisslein T, Emons G, Hofbauer LC.

J Bone Miner Res. 2005 Nov;20(11):2036-43.

11.
12.

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.

J Bone Miner Res. 2000 Aug;15(8):1459-66.

13.

The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.

Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL.

Endocrinology. 2000 Dec;141(12):4768-76.

PMID:
11108292
14.

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.

Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S.

Biochem Biophys Res Commun. 2001 Jan 12;280(1):334-9.

PMID:
11162519
15.

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.

J Bone Miner Res. 2000 Sep;15(9):1766-75.

16.

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

Michael H, Härkönen PL, Väänänen HK, Hentunen TA.

J Bone Miner Res. 2005 Dec;20(12):2224-32.

17.
18.

Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.

Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.

Endocrinology. 2000 Dec;141(12):4711-9.

PMID:
11108286
19.

Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture.

Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S.

J Endocrinol. 2003 Mar;176(3):339-48.

Supplemental Content

Support Center